Corporate Banner
Satellite Banner
Technology Networks Header
Monday, November 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
HPLC Determination of Product Adulteration and Authenticity
Friday, January 03, 2014
Determination of product authentication and adulteration by using novel spectro-electro array platform.

New Genedata Expressionist for MS Gains Increased Adoption in Metabolomics R&D
Tuesday, December 17, 2013
Version 8.0 brings new workflows for integrated processing of LC- and GC-MS data on vendor-agnostic platform.

Agilent Introduces New ProPulse NMR Platform
Tuesday, November 12, 2013
Compact system provides simple, walk-up performance for applied chemistry research, drug discovery, food science and metabolomics.

Thermo Scientific Mass Spec User Meetings
Tuesday, October 15, 2013
Guest presenters from Harvard Medical School, Stanford, Michigan State University, Pfizer and Bristol Meyers Squibb and other organizations will describe how they apply the latest high resolution accurate mass spectrometry technology to a variety of challenging life science experiments.

Hepregen Launches First Dual-Species HepatoPac™ DMPK Assay Kits
Wednesday, September 25, 2013
Rat and human liver cells on a single tissue culture plate designed for high efficiency data collection.

Hepregen Launches First Rat HepatoPac™ DMPK Assay Kits
Thursday, September 12, 2013
Companions to recently introduced human HepatoPac™ DMPK application-oriented kit.

Bruker Announces Novel Approach for IEM Screening by NMR
Thursday, September 05, 2013
Clinical IEM-by-NMR screening study in Turkey measures 65 metabolites in urine simultaneously, including 20 endogenous metabolites and 45 metabolites associated with inborn errors of metabolism.

Roche Launches New Metabolite Tests for its Cedex Bio Systems
Monday, July 08, 2013
Adding iron and phosphate tests to Cedex Bio test menu.

Technical Seminar at Metabolomics Society International Conference
Monday, June 17, 2013
Technical showcase will take place in the Lomond Theatre of the Scottish Exhibition and Conference Center in Glasgow.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 334
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv